Maynard Um, Wells Fargo: Reiterates an Outperform rating, and a $30 to $32 “valuation range.” “Bears may point to a lack of operating p00M-649 Exam and demorofit upside despite the revenue beat. However, we believe initiatives HP has put in place will ultimately result in operating leverage going forward and note that on both a relative and absolute basis, HP’s results and guidance were pretty good.
We believe investors should be encouraged by 1) yet another strong cash flow performance (our core FY2015 thesis) and 2) what appears to be a b00M-649 Exam and demoottoming in some business segments or at least what we believe is line of sight to a bottom. We believe HP is executing very well in a tough environment and we maintain our thesis that FY2014 should see a bottom in a number of businesses, setting up for FY2015 growth. More importantly, FY2015 cash flow should see stronger growth (more closely aligning to net income) as some one-time pressures ($1.4B cash restructuring charge in particular) should not recur. We reiterate our Outperform rating.”
Brent Bracelin, Pacific Crest: Reiterates a Sector Perform rating, and raises his price target to $30 from $26. “The most encouraging development from HP’s October results was the 12% and 4% q/q revenue increases from EG and Printin00M-649 Exam and demog. These were the biggest reversals seen in more than two years. These are HP’s two most important segments, accounting for 80% to 85% of profits, and should dictate the size of any turnaround [...] HP is executing a turnaround, but we are not sure if it is sustainable.”
http://www.testonside.com/00M-649.html
We believe investors should be encouraged by 1) yet another strong cash flow performance (our core FY2015 thesis) and 2) what appears to be a b00M-649 Exam and demoottoming in some business segments or at least what we believe is line of sight to a bottom. We believe HP is executing very well in a tough environment and we maintain our thesis that FY2014 should see a bottom in a number of businesses, setting up for FY2015 growth. More importantly, FY2015 cash flow should see stronger growth (more closely aligning to net income) as some one-time pressures ($1.4B cash restructuring charge in particular) should not recur. We reiterate our Outperform rating.”
Brent Bracelin, Pacific Crest: Reiterates a Sector Perform rating, and raises his price target to $30 from $26. “The most encouraging development from HP’s October results was the 12% and 4% q/q revenue increases from EG and Printin00M-649 Exam and demog. These were the biggest reversals seen in more than two years. These are HP’s two most important segments, accounting for 80% to 85% of profits, and should dictate the size of any turnaround [...] HP is executing a turnaround, but we are not sure if it is sustainable.”
http://www.testonside.com/00M-649.html